CLINICAL_TRIALS
trial_result
· 2020-04-20
Clinical Trial Update: A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy [Phase 2]
Summary
Phase IIa study of TAS-205 for Duchenne Muscular Dystrophy has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2020-04-20